Erna Kaleva

Helsinki University Hospital

Papers

1

Total Citations

25

H-Index

1

About

Erna Kaleva is a leading figure in radiation oncology, whose work has fundamentally advanced the precision and safety of stereotactic body radiotherapy (SBRT). Her research centers on the dosimetric optimization of cancer treatments, with a particular focus on prostate cancer. In her seminal 2016 study, "Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer," Kaleva conducted a rigorous comparative analysis of four distinct SBRT delivery methods across eight patients. This work, which has garnered 25 citations, systematically evaluated critical dosimetric characteristics, monitor unit efficiency, and overall delivery performance. By providing a clear, evidence-based framework for technique selection, her contribution has directly informed clinical decision-making, helping to maximize tumor control while minimizing collateral damage to healthy tissue. Her meticulous approach to quantifying treatment plan quality has established a benchmark for the field, solidifying her reputation as a key contributor to the evolution of non-invasive cancer therapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Dosimetric Comparison and Evaluation of 4 Stereotactic Body Radiotherapy Techniques for the Treatment of Prostate Cancer
25 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Helsinki University Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago